Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 08-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 199 | 2,573 | 4,906 | 0 | 11,137 |
| Receivables | N/A | N/A | 256 | 256 | 212 |
| TOTAL | $4,191 | $2,777 | $5,330 | $256 | $11,545 |
| Non-Current Assets | |||||
| PPE Net | 62 | 119 | 153 | 0 | 122 |
| Intangibles | 12,527 | 13,220 | 13,983 | 0 | 13,704 |
| Other Non-Current Assets | 129 | 199 | 0 | 0 | 0 |
| TOTAL | $12,718 | $13,539 | $14,136 | $0 | $13,826 |
| Total Assets | $16,908 | $16,316 | $19,466 | $256 | $25,371 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,653 | N/A | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 2,184 | 1,248 | 1,623 | 0 | 803 |
| Accrued Expenses | 1,487 | 1,410 | 1,912 | 0 | 543 |
| TOTAL | $7,342 | $2,699 | $3,590 | $0 | $1,400 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 39 | 56 | 0 | 0 | 0 |
| TOTAL | $2,957 | $3,137 | $3,258 | $0 | $3,193 |
| Total Liabilities | $10,300 | $5,835 | $6,848 | $0 | $4,593 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38 | 38 | N/A | N/A | N/A |
| Common Shares | 5 | 150 | 1,306 | 0 | 1,305 |
| Retained earnings | -88,132 | -75,624 | -58,307 | 0 | -49,728 |
| Other shareholders' equity | -27 | 294 | 619 | 0 | 635 |
| TOTAL | $6,609 | $10,481 | $12,618 | $0 | $20,779 |
| Total Liabilities And Equity | $16,908 | $16,316 | $19,466 | $0 | $25,371 |